Current State of Self-Administered Brief Computerized Cognitive Assessments for Detection of Cognitive Disorders in Older Adults: A Systematic Review
The Journal of Prevention of Alzheimer's disease
Tsoy, E., Zygouris, S., et al. (2021).
The Journal of Prevention of Alzheimer's disease, 8(3), 267-276.
This systematic review investigates the psychometric properties and clinical applicability of self-administered computerized assessment tools for detecting mild cognitive impairment (MCI) and dementia in adults, 50 years or older.
National Institute of Neurological Disorders and Stroke; Global Brain Health Institute
January 1, 2000 to April 20, 2020
Original, peer-reviewed published studies with a control sample
17
Seventeen studies investigating the psychometric properties and clinical applicability of self-administered assessment tools for detecting MCI and dementia in adults, 50 years or older, identified 10 brief computer-based measures. The authors found significant variability in administration characteristics, validation, and psychometric qualities across measures. For identifying either cognitive impairment (i.e., MCI and dementia combined), three tools [Computerized Self Test, digitally translated Self-Administered Gerocognitive Examination, untitled test] reported sensitivity ranging from 0.71 to 0.99 and specificity ranging from 0.72 to 0.95. "In general, despite the promise that self-administered cognitive tests hold for clinical applications, important gaps in scientific rigor in development, validation, and feasibility studies of these measures remain" (p. 272).
For identifying MCI in adults, six tools [Computer Assessment of Memory and Cognitive Impairment, Computer-Administered Neuropsychological Screen for MCI, CNS Vital Signs, CogState, CogState Brief Battery, digitally translated Self-Administered Gerocognitive Examination] reported sensitivity ranging from 0.41 to 0.90 and specificity ranging from 0.64 to 0.94.
For identifying dementia in adults, three tools [Computerized Cognitive Screening, CNS Vital Signs, CogState Brief Battery] reported sensitivity ranging from 0.53 to 0.94 and specificity ranging from 0.50 to 0.94.
